{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Deep Origin says BioAge validated computational drug candidates in laboratory tests","author_name":"techandbusiness.org · AI","thumbnail_url":"https://s.yimg.com/cv/apiv2/cv/apiv2/social/images/yahoo-finance-default-logo.png","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · AI</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/CUvoiDHhRMU5rjLSJR7feO\" style=\"color:#fff;text-decoration:none;\">Deep Origin says BioAge validated computational drug candidates in laboratory tests</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Deep Origin announced a multi-target drug discovery collaboration with BioAge Labs and said BioAge's laboratory had validated small-molecule hits against the partnership's first target. The platform d...</p>\n    </blockquote>"}